<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Superior sagittal sinus <z:mp ids='MP_0005048'>thrombosis</z:mp> (SSST) has been reported to be caused by <z:hpo ids='HP_0003256'>coagulopathy</z:hpo> following oral contraceptive therapy, <z:chebi fb="0" ids="53092">DIC</z:chebi>, <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> around the sinus, compression from a <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e>, infiltration of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e>, and an inherited deficiency of proteins C and S, but SSST associated with <z:e sem="disease" ids="C0376545" disease_type="Neoplastic Process" abbrv="">hematological malignancies</z:e> and L-asparaginase (L-Asp) therapy is rare </plain></SENT>
<SENT sid="1" pm="."><plain>We report a case of an adult patient with <z:hpo ids='HP_0006721'>acute lymphoblastic leukemia</z:hpo> (ALL) who developed SSST during the remission induction therapy </plain></SENT>
<SENT sid="2" pm="."><plain>A 25-year-old man was admitted with left <z:e sem="disease" ids="C0015464" disease_type="Disease or Syndrome" abbrv="">facial nerve palsy</z:e> and, following bone marrow <z:hpo ids='HP_0002835'>aspiration</z:hpo> and lumbar puncture, he was diagnosed as having <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">T-ALL</z:e> with <z:chebi fb="7" ids="29425,29426,29441,29447">CNS</z:chebi> involvement </plain></SENT>
<SENT sid="3" pm="."><plain>He received a 1-AdVP regimen as remission induction therapy and intrathecal administration of <z:chebi fb="0" ids="44185">methotrexate</z:chebi> and <z:chebi fb="0" ids="28680">cytarabine</z:chebi> </plain></SENT>
<SENT sid="4" pm="."><plain>On day 29, he had a <z:e sem="disease" ids="C0234533" disease_type="Disease or Syndrome" abbrv="">generalized convulsion</z:e> and SSST was demonstrated by imaging tests </plain></SENT>
<SENT sid="5" pm="."><plain>Lymphoid <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">malignancy</z:e> (ALL in particular), the use of L-Asp, <z:chebi fb="7" ids="29425,29426,29441,29447">CNS</z:chebi> involvement, and intrathecal chemotherapy might be risk factors for the occurrence SSST </plain></SENT>
<SENT sid="6" pm="."><plain>When a patient with those factors develops any neurological symptoms, we should pay attention to the occurrence of SSST, as well as <z:hpo ids='HP_0001297'>stroke</z:hpo> or <z:chebi fb="7" ids="29425,29426,29441,29447">CNS</z:chebi> involvement, though SSST is rare </plain></SENT>
</text></document>